Discriminating Between Response Types in Infliximab-Treated Patients With Crohn's Disease: Sensitivity and Specificity of Combined Assessment of Infliximab Trough Levels and Anti-Drug Antibodies

被引：0
|
作者：
Steenholdt, Casper
Thomsen, Ole O.
Brynskov, Jorn
Bendtzen, Klaus
Ainsworth, Mark A.
机构：
来源：
GASTROENTEROLOGY | 2010年 / 138卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
W1270
引用
收藏
页码：S687 / S688
页数：2
相关论文
共 50 条
  • [1] Discriminating between response types in infliximab-treated patients with Crohn's disease: Sensitivity and specificity of combined assessment of infliximab trough levels and antidrug antibodies
    Steenholdt, Casper
    Bendtzen, Klaus
    Thomsen, Ole Ostergaard
    Brynskov, Jorn
    Ainsworth, Mark
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2010, 45 : 59 - 59
  • [2] INCIDENCE AND CLINICAL OUTCOME OF ANTI-DRUG ANTIBODIES IN INFLIXIMAB-TREATED PATIENTS
    Bartoli, F.
    Fiori, G.
    Galluccio, F.
    Petroni, G.
    Pratesi, S.
    Matucci, A.
    Vultaggio, A.
    Nacci, F.
    Nencini, F.
    Maggi, E.
    Matucci-Cerinic, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 514 - 514
  • [3] Infliximab trough levels and anti-drug antibodies after induction predict long-term clinical remission in infliximab-treated patients with inflammatory bowel disease
    Bodini, G.
    Del Nero, L.
    Giannini, E. G.
    Tolone, S.
    De Bortoli, N.
    Anjali, J.
    Baldissarro, I.
    Savarino, V.
    Savarino, E.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S408 - S409
  • [4] The association between drug levels, anti-drug antibodies, and therapeutic response during infliximab therapy in pediatric Crohn's disease
    Stein, R. E.
    Lee, D. Y.
    Leonard, M. B.
    Thayu, M.
    Herskovitz, R. M.
    Kerbowski, T.
    Baldassano, R. N.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S434 - S434
  • [5] Clinical correlations of infliximab trough levels and antibodies to infliximab in Korean patients with Crohn's disease
    Oh, E. H.
    Ko, D. -H.
    Seo, H.
    Chang, K.
    Kim, G. -U.
    Song, E. M.
    Seo, M.
    Lee, H. -S.
    Hwang, S. W.
    Yang, D. -H.
    Ye, B. D.
    Byeon, J. -S.
    Myung, S. -J.
    Yang, S. -K.
    Park, S. H.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S283 - S284
  • [6] Infliximab trough levels may predict sustained response to infliximab in patients with Crohn's disease
    Bortlik, Martin
    Duricova, Dana
    Malickova, Karin
    Machkova, Nadezda
    Bouzkova, Eva
    Hrdlicka, Ludek
    Komarek, Arnost
    Lukas, Milan
    JOURNAL OF CROHNS & COLITIS, 2013, 7 (09): : 736 - 743
  • [7] Clinical correlations of infliximab trough levels and antibodies to infliximab in South Korean patients with Crohn's disease
    Oh, Eun Hye
    Ko, Dae-Hyun
    Seo, Hyungil
    Chang, Kiju
    Kim, Gwang-Un
    Song, Eun Mi
    Seo, Myeongsook
    Lee, Ho-Su
    Hwang, Sung Wook
    Yang, Dong-Hoon
    Ye, Byong Duk
    Byeon, Jeong-Sik
    Myung, Seung-Jae
    Yang, Suk-Kyun
    Park, Sang Hyoung
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (08) : 1489 - 1496
  • [8] Clinical correlations of infliximab trough levels and antibodies to infliximab in South Korean patients with Crohn's disease
    Eun Hye Oh
    Dae-Hyun Ko
    Hyungil Seo
    Kiju Chang
    Gwang-Un Kim
    Eun Mi Song
    Myeongsook Seo
    Ho-Su Lee
    Sung Wook Hwang
    Dong-Hoon Yang
    Byong Duk Ye
    Jeong-Sik Byeon
    Seung-Jae Myung
    Suk-Kyun Yang
    Sang Hyoung Park
    World Journal of Gastroenterology, 2017, 23 (08) : 1489 - 1496
  • [9] Risk factors for the development of anti-drug antibodies to infliximab and adalimumab in Crohn's disease
    Khoo, E.
    Lord, A.
    Hanigan, K.
    Croft, A.
    Radford-Smith, G.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S378 - S379
  • [10] Anti-drug antibodies and low serum trough infliximab levels correlate with disease activity measures in spondyloarthritis patients on an as-needed infliximab treatment
    Patil, Abhishek
    Upadhyaya, Sundeep
    Dawar, Reetika
    Dadhaniya, Nikunjkumar
    Sood, Isha
    Gupta, Sirinder J.
    Handa, Rohini
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2019, 22 (09) : 1638 - 1643
12345